Literature DB >> 20805098

Reduction of door-to-balloon time by new performance processes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

.   

Abstract

The aim of this study was to determine whether the adoption of new performance processes reduced the door-to-balloon time for primary percutaneous coronary intervention (PCI). To reduce the door-to-balloon time, we adopted 3 new performance processes: concurrent activation at the emergency department rather than stepwise activation; direct phone call rather than using a pager or message; patient transferred to catheterization laboratory before the PCI team arrive. A total of 139 consecutive patients were compared before and after the new performance processes. After the adoption of the new processes, median door-to-balloon time reduced significantly from 133 to 76 minutes (P < .0001) and patients undergoing primary PCI within 90 minutes increased significantly from 16% to 72% (P < .0001). Among the subdivisions of the door-to-balloon time, door-to-consent time and door-to-laboratory arrival time decreased significantly (50.0 vs 20.5 minutes, P < .0001; 95.0 vs 40.0 minutes, P < .0001, respectively).

Entities:  

Mesh:

Year:  2010        PMID: 20805098     DOI: 10.1177/0003319710380682

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  2 in total

1.  Implementation of multiple strategies for improved door-to-balloon time in patients with ST-segment elevation myocardial infarction.

Authors:  Ming-Wei Pan; Shou-Yen Chen; Chun-Chi Chen; Wei-Jan Chen; Chi-Jen Chang; Chia-Pin Lin; Yi-Ming Weng; Yu-Cheng Chen
Journal:  Heart Vessels       Date:  2013-03-19       Impact factor: 2.037

2.  Factors related to prehospital time delay in acute ST-segment elevation myocardial infarction.

Authors:  Yong Hwan Park; Gu Hyun Kang; Bong Gun Song; Woo Jung Chun; Jun Ho Lee; Seong Youn Hwang; Ju Hyeon Oh; Kyungil Park; Young Dae Kim
Journal:  J Korean Med Sci       Date:  2012-07-25       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.